Home Financial Results

Financial Results

Jubilant Life Sciences – Q4 & 12M’FY19 Results

  JUBILANT REPORTS RECORD PERFORMANCE IN FY'19 Revenue up 21% YoY to Rs. 9,111 Crore; EBITDA up 14% YoY to Rs 1,775 Crore Normalised PAT at Rs. 855 Crore with EPS at Rs. 54 per share Q4'FY19 Revenue at Rs 2,386...